| Literature DB >> 2667103 |
Abstract
According to the present experience, ciprofloxacin seems to be a new promising drug for the treatment of enteric salmonella carriage stage. This paper reviews results with ciprofloxacin and older drugs. While the cure rates in previous studies were about 70%, it was at least 90% with ciprofloxacin although the treatment time was shorter and the rate of side effects was lower. However the final place of ciprofloxacin on this indication needs to be investigated further.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2667103
Source DB: PubMed Journal: Scand J Infect Dis Suppl ISSN: 0300-8878